Penicillamine has FDA approval as a treatment for Wilson disease and cystinuria. It is used as an off-label treatment option for lead poisoning in children. It is considered a conventional disease-modifying antirheumatic drug (DMARD). This activity presents penicillamine's indications, contraindications, and side effects and highlights the interprofessional team's role in managing patients with Wilson disease and lead poisoning.
Copyright © 2025, StatPearls Publishing LLC.